WebAug 2, 2024 · The most common side effects of azithromycin are diarrhea, nausea, and abdominal pain. Other side effects, which are less common, and occur in less than 1% of … WebMar 25, 2011 · Other Name: Erythromycin ethylsuccinate Experimental: Azithromycin The dose of Azithromycin was determined based on our dose response curve obtained on 10 healthy subjects who were given three different doses of Azithromycin, 50 mg, 100 mg and 133 mg and underwent breath testing to determine the gastric emptying half-time.
Azithromycin Alternatives Compared - Drugs.com
WebDec 2, 2024 · The bottom line. A Z-Pak can be a convenient and effective option for treating several types of infections. Each package contains six azithromycin tablets typically taken over 5 days. Common Z-Pak side effects include diarrhea, nausea and vomiting, and abdominal pain. Z-Pak is available as a lower-cost generic. WebAzilsartan is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda.It is marketed in tablet form under the brand name Edarbi as the prodrug azilsartan medoxomil.. The most common adverse reaction in adults is diarrhea.. It is available as a generic medication. It is also sold as a combination drug with … ccxprocess 是什么
Azithromycin C38H72N2O12 - PubChem
WebAzithromycin is used to treat a wide variety of bacterial infections. Learn more about this drug here . 1 . This is a generic drug. The average cost for 1 Disp Pack, 6 tablets each of the generic (azithromycin) is $34.95. You can buy azithromycin at the discounted price of $17.31 by using the WebMDRx coupon, a savings of 50%. WebOct 12, 2024 · Brand Names: Azithromycin 3 Day Dose Pack, Azithromycin 5 Day Dose Pack, Zithromax, Zithromax IV, Zithromax TRI-PAK, Zithromax Z-Pak ... Other drugs may affect azithromycin, including prescription and over-the-counter … WebAzithromycin was given to 55 cases of lower respiratory tract infections in the doses of 500 mg on day 1, followed by 250 mg on days 2-5. It produced bacteriological cure in 70.8% patients and clinical cure or improvement in 69.09% of patients. 4.27% of patients had throat colonisation with new organisms, of which 9.09% needed a second antibiotic. ccxprocess とは